The Four Common Signs of Opioid Abuse: Detection and Assessment for Claims Managers

Learn to identify aberrant opioid use patterns in your insurance claims through four key warning signs.

Published 4 April 2026

Introduction

Opioid dependence develops through two distinct pathways. The first is iatrogenic: a claimant takes opioids exactly as prescribed but develops physical dependence through biochemical adaptation. The second is behavioural: a claimant develops problematic use patterns that exceed medical necessity, such as escalating doses, seeking opioids from multiple prescribers, or using in ways that indicate loss of control.

As a claims manager, you need to distinguish between these pathways because they require different responses. Iatrogenic dependence in a claimant taking opioids as prescribed requires careful de-prescribing support. Behavioural indicators of opioid misuse require intervention: escalation to addiction specialists, monitoring intensification, or dose limitation.

This guide equips you with recognition of the four most common signs of opioid misuse in your claims. When you see these patterns, you know your claimant needs intervention.

The Four Common Signs of Opioid Abuse

Sign 1: Dose Escalation Beyond Clinical Need

The most visible sign of opioid misuse is opioid dose escalation that doesn't correspond to clinical need.

What Appropriate Dose Escalation Looks Like

When opioids are working appropriately, dose increases are slow and deliberate. The prescriber increases dose in response to documented inadequate pain control, with clear clinical justification in the notes. For example: "Patient reports pain inadequately controlled on current 20mg daily; imaging confirms ongoing pathology; increasing to 30mg daily for improved analgesia and functional restoration." Between dose increases, there's typically a 1-2 week interval allowing assessment of response at the new dose. The dose trajectory is measured, not steep.

What Problematic Escalation Looks Like

Problematic escalation appears as rapid, sustained dose increases without corresponding documented clinical improvement. For example, a claimant may be escalated from 10mg to 20mg to 40mg to 60mg to 80mg over 12 weeks, with each increase occurring before adequate response time at the lower dose. Documentation may show pain scores remain high despite escalation; function may worsen despite higher doses. This pattern indicates the claimant is seeking dose increases for reasons beyond pain control, suggesting behaviour-related misuse.

How You Detect It in Your Claims

Create a simple timeline of opioid doses from prescription records and claims file. Plot doses month by month. Does the escalation look like a gradual slope or a steep staircase? Cross-reference dose changes with clinical documentation. Do dose increases follow clinical visits where inadequate pain control was documented? Or do they appear before such documentation or without clear clinical trigger?

The Importance of Pain-Dose Mismatch

A critical red flag is when pain escalates despite opioid dose increases, or when function worsens. This suggests opioids aren't providing benefit. In this scenario, continued escalation indicates the claimant is developing escalating opioid use independent of pain relief, a key marker of misuse. Alert the prescriber to this pattern and request reassessment of pain management strategy.

Sign 2: Doctor Shopping and Multiple Prescribers

One of the clearest signs of opioid misuse is when a claimant obtains opioid prescriptions from multiple prescribers who are unaware of each other.

How Doctor Shopping Works

A claimant might have a primary treating doctor but also visit an emergency department, urgent care centre, or another GP on the pretext of acute pain. Each prescriber, unaware of the others, issues opioid prescriptions. The claimant may also use multiple pharmacies to avoid triggering alerts about overlapping prescriptions. Over time, the claimant accumulates opioid supply from multiple sources, far exceeding the dose prescribed by any single provider.

How to Detect It

Your first step is to audit the claim file for all opioid prescriptions. Who are the prescribers? Are there multiple? Are prescriptions overlapping in time (e.g., claimant has opioid supply from Provider A and Provider B simultaneously)? Australia's Real-Time Prescription Monitoring (RTPM) system allows prescribers to check whether a claimant is obtaining controlled drugs from multiple providers. Request RTPM reports for your claimant. If they show multiple opioid prescribers, that's your evidence of doctor shopping. Speak with the claimant's pharmacy to ask whether they've filled prescriptions from multiple providers.

The Regulatory Response

If doctor shopping is detected, you have clear grounds for intervention. Responsible action includes: contacting all identified prescribers to advise them of multiple-source prescribing; working with providers to establish a single coordinating prescriber who will manage all opioid supply; requiring RTPM checks before any future opioid prescription; and referring the claimant for addiction assessment. Some health systems establish formal "opioid prescribing agreements" where the claimant commits to obtaining opioids from a single prescriber and pharmacy, with the understanding that violation of the agreement results in cessation of opioid supply.

Sign 3: Early Prescription Refills and Supply Requests

When a claimant regularly requests opioid prescriptions or refills before supply is exhausted, that indicates faster-than-prescribed consumption.

Detecting Early Refill Patterns

Track prescription dates and supply durations. If a claimant is prescribed 30 tablets of oxycodone with a dose of 10mg twice daily, the expected supply duration is 7-8 days. If the claimant requests a refill 5 days after the prescription, that's early. If early refills are a pattern rather than a one-off event, that indicates the claimant is consuming opioids faster than prescribed. Calculate expected supply duration at prescribed doses; any refill request before that date is a red flag.

Common Explanations and How to Evaluate Them

When confronted with early refill requests, claimants may offer explanations: "I lost the script", "The pharmacist lost my medication", "I forgot I had more at home", or "I took extra because the pain was bad." Some explanations are credible; some indicate behaviour-related misuse. Lost scripts may happen rarely. If a claimant reports lost scripts multiple times, that becomes suspicious. If pain is genuinely escalating, you'd expect to see documentation of increased pain in clinical visits, not just medication-seeking behaviour.

Documentation Requirements for Early Refills

Establish a clear policy: early refills require prescriber approval and documented justification. For example, if your claimant requests a refill 5 days early, the prescriber should document why. Valid reasons might include dose increase approved at a recent visit; invalid reasons would be "claimant requested" without clinical justification. By requiring documentation, you create a paper trail that either confirms clinical need or reveals unsupported escalation.

Progressive Escalation of Early Refills

Pay attention to trends. A single early refill might be coincidence; regular early refill requests indicate escalating consumption. If your claimant moves from requesting refills 2-3 days early to 1-2 weeks early, that's escalating drug use. Each interval represents claimant behaviour changing to consume larger amounts in shorter time, a key indicator of misuse.

Sign 4: Behavioural Changes and Appointment Non-Compliance

Behavioural changes often accompany developing opioid misuse. These changes can be detected in your claims data.

Appointment Non-Compliance and Missed Contact

Claimants engaged in appropriate pain management attend scheduled appointments, particularly specialist assessments and pain management reviews. When a claimant develops opioid misuse, they may avoid contact with providers who might identify the problem. They might miss appointments with addiction specialists, pain specialists, or even primary care providers. Simultaneously, they may continue requesting opioid prescriptions (suggesting medication-seeking behaviour) while avoiding clinical contact that would assess appropriateness.

Look for patterns: claimant misses pain specialist appointments but is prompt with prescription collection; claimant avoids mental health appointments but requests opioid refills by phone; claimant declines participation in physiotherapy but continues opioid requests. These selective patterns indicate the claimant is prioritizing medication access while avoiding oversight.

Social and Occupational Withdrawal

In your claims data, look for changes in employment status, social engagement, or functional reports. A claimant who was initially working part-time or engaging in rehabilitation may gradually withdraw from these activities. Family members may report increasing isolation. These social changes can accompany developing opioid dependence, where the opioid use becomes increasingly central to the claimant's life and engagement with other activities decreases.

Resistance to De-Prescribing and Non-Opioid Treatments

As misuse develops, claimants often resist attempts to modify opioid therapy. They may refuse participation in physiotherapy, psychological therapy, or other evidence-based pain management approaches. They may resist dose reductions or express strong preference for specific opioid formulations. Documentation of these refusals is important. Comments like "I'll only take oxycodone, not morphine", "I refuse physio and just want the pain relief", or "I don't want to see the psychologist; I just need my medication increased" are red flags for behaviour-related misuse.

Managing Patients with Behavioural Signs

When you identify behavioural red flags, the appropriate response is multi-faceted. First, discuss observations with the claimant. Missed appointments may reflect practical barriers (transport, childcare) rather than medication-seeking behaviour. Some barriers can be addressed. Second, contact treating providers to ensure they're aware of the pattern and to coordinate response. Third, consider referral for formal addiction and mental health assessment. Fourth, implement structured opioid prescribing agreement: if the claimant wants to continue opioid therapy, they must agree to regular appointment attendance, single-prescriber arrangement, and participation in pain management activities. Failure to comply results in opioid therapy cessation.

When Multiple Signs Converge

Individual signs may be ambiguous. A single early refill might be explained; a single missed appointment might reflect scheduling conflict. When multiple signs converge, the picture becomes clear:

• Dose escalation plus early refills indicates accelerating consumption without clinical improvement
• Multiple prescribers plus early refills indicates deliberate attempts to accumulate supply
• Appointment non-compliance plus resistant to non-opioid treatment plus dose escalation indicates behaviour-driven misuse
• Doctor shopping plus requests for specific opioid doses plus missed appointments indicates well-established misuse pattern

When you see clustering of these signs, escalate immediately for medication review and addiction specialist assessment. The pattern indicates behaviour-related opioid misuse requiring intervention.

Integrating Detection Into Your Claims Management

Key Takeaways for Claims Managers

The four most common signs of opioid misuse are dose escalation without clinical improvement, obtaining opioids from multiple prescribers, requesting refills before supply is exhausted, and behavioural changes including appointment non-compliance and resistance to non-opioid treatment. Individual signs may be ambiguous; clustering of signs indicates clear misuse requiring intervention. Your response should include coordinating single-prescriber opioid management, requesting addiction specialist assessment, implementing prescribing agreements, and escalating for independent medication review. Early detection of these signs allows early intervention before escalation becomes severe.

For more information about aberrant opioid behaviours, refer to published addiction medicine literature and consult with addiction specialists or pharmacist medication review services who can provide detailed assessment of concerning patterns in your claims.